Literature DB >> 15688282

T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.

Mark P Eggena1, Banson Barugahare, Martin Okello, Steven Mutyala, Norman Jones, Yifei Ma, Cissy Kityo, Peter Mugyenyi, Huyen Cao.   

Abstract

Immune activation is thought to play a major role in the pathogenesis of human immunodeficiency virus (HIV). This effect may be particularly relevant in Africa, where endemic coinfections may contribute to disease progression, perhaps as a consequence of enhanced immune activation. We investigated the expression of CD38 and human leukocyte antigen (HLA)-DR on T cells in 168 HIV-seropositive volunteers in Uganda. We observed higher levels of CD4(+) and CD8(+) T cell activation in Uganda, compared with those reported in previous studies from Western countries. Coexpression of CD38 and HLA-DR on both CD4(+) and CD8(+) T cell subsets was directly correlated with viral load and inversely correlated with CD4(+) T cell counts. In antiretroviral therapy (ART)-naive volunteers, viral load and CD4(+) T cell count had stronger associations with CD8(+) and CD4(+) T cell activation, respectively. Virus suppression by ART was associated with a reduction in T cell activation, with a stronger observed effect on reducing CD8(+) compared with CD4(+) T cell activation. The presence of coinfection was associated with increased CD4(+) T cell activation but, interestingly, not with increased CD8(+) T cell activation. Our results suggest that distinct mechanisms differentially drive activation in CD4(+) and CD8(+) T cell subsets, which may impact the clinical prognostic values of T cell activation in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15688282     DOI: 10.1086/427516

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.

Authors:  Robert C Kalayjian; Rhoderick N Machekano; Nesrine Rizk; Gregory K Robbins; Rajesh T Gandhi; Benigno A Rodriguez; Richard B Pollard; Michael M Lederman; Alan Landay
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 2.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

3.  Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.

Authors:  Peter W Hunt; Huyen L Cao; Conrad Muzoora; Isaac Ssewanyana; John Bennett; Nneka Emenyonu; Annet Kembabazi; Torsten B Neilands; David R Bangsberg; Steven G Deeks; Jeffrey N Martin
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

4.  Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus.

Authors:  Samuel Malamba; Taylor Sandison; John Lule; Arthur Reingold; Jordan Walker; Grant Dorsey; Jonathan Mermin
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

5.  Infection with different hiv subtypes is associated with CD4 activation-associated dysfunction and apoptosis.

Authors:  Stephanie Bousheri; Candace Burke; Isaac Ssewanyana; Richard Harrigan; Jeffrey Martin; Peter Hunt; David R Bangsberg; Huyen Cao
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

6.  The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.

Authors:  Isaac Ssewanyana; Chris A R Baker; Theodore Ruel; Stephanie Bousheri; Moses Kamya; Grant Dorsey; Philip J Rosenthal; Edwin Charlebois; Diane Havlir; Huyen Cao
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

7.  Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

Authors:  Sabine M Hermans; Agnes N Kiragga; Petra Schaefer; Andrew Kambugu; Andy I M Hoepelman; Yukari C Manabe
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

8.  Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection.

Authors:  Georgina Thorborn; Laura Pomeroy; Heidi Isohanni; Melissa Perry; Barry Peters; Annapurna Vyakarnam
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

9.  Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance.

Authors:  Damalie Nakanjako; Agnes Kiragga; Fowzia Ibrahim; Barbara Castelnuovo; Moses R Kamya; Philippa J Easterbrook
Journal:  AIDS Res Ther       Date:  2008-10-28       Impact factor: 2.250

10.  Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS).

Authors:  David M Murdoch; Melinda S Suchard; Willem D F Venter; Patrick Mhlangu; Janet S Ottinger; Charles Feldman; Annelies Van Rie; Deborah K Glencross; Wendy S Stevens; Kent J Weinhold
Journal:  AIDS Res Ther       Date:  2009-07-16       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.